Redefining clinical trials: Adopting AI for speed, volume and diversity
IBM Big Data Hub
MAY 6, 2024
For instance, the FDA released guidance in November 2020 titled, “Enhancing the diversity of clinical trial populations.” Learning from historical protocol data and using synthetically generated scenario events to optimize inclusion and exclusion criteria can be powerful for achieving efficient trial design.
Let's personalize your content